Axillary reverse mapping in breast cancer: A Canadian experience

Journal of Surgical Oncology

Volumn 110, Issue 7, 2014, Pages 791-795

  Kuusk, Urve ^a,b   Seyednejad, Nazgol ^a,b   McKevitt, Elaine C ^a,b   Dingee, Carol K ^a,b   Wiseman, Sam M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

complications; lymphatic mapping; lymphedema; sentinel lymph node biopsy

Indexed keywords

SULFUR; TECHNETIUM 99M; TECHNETIUM SULFUR COLLOID TC 99M;

ANESTHESIA; ARM; ARM LYMPHEDEMA; ARTICLE; AXILLARY LYMPH NODE; AXILLARY LYMPH NODE DISSECTION; AXILLARY REVERSE LYMPHATIC MAPPING; BREAST CANCER; CANCER SURGERY; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHATIC SYSTEM EXAMINATION; LYMPHEDEMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; ADULT; AGED; AXILLA; BREAST NEOPLASMS; CANCER STAGING; DIAGNOSTIC USE; FOLLOW UP; LYMPH NODE; MASTECTOMY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SCINTISCANNING; SURGERY;

ADULT; AGED; ARM; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHEDEMA; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 84922274365     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23720     Document Type: Article

References (25)

1. Noguchi M:, Axillary reverse mapping for preventing lymphedema in axillary lymph node dissection and/or sentinel lymph node biopsy. Breast Cancer 2010; 17: 155-157.
2. Noguchi M, Noguchi M, Nakano Y, et al.,: Axillary reverse mapping using a fluorescence imaging system in breast cancer. J Surg Oncol 2012; 105: 229-234.
3. Deng H, Chen L, Jia W, et al.,: Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients. J Cancer Res Clin Oncol 2011; 137: 1869-1874.
4. Iwase H, Yamamato Y, Kawasoe T, et al.,: Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment. Surg Today 2009; 39: 374-380.
5. Klimberg VS:, A new concept toward the prevention of lymphedema: Axillary reverse mapping. J Surg Oncol 2008; 97: 563-564.
6. Bedrosian I, Babiera GV, Mittendorf EA, et al.,: A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 2010; 116: 2543-2548.
7. Khan SA:, Axillary reverse mapping to prevent lymphedema after breast cancer surgery: Defining the limits of the concept. J Clin Oncol 2009; 27: 5494-5496.
8. Thompson M, Korourian S, Henry-Tillman R, et al.,: Axillary reverse mapping (ARM): A new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 2007; 14: 1890-1895.
9. Boneti C, Korourian S, Bland K, et al.,: Axillary reverse mapping: Mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg 2008; 206: 1038-1042.
10. Nos C, Kaugmann G, Clough KB, et al.,: Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 2008; 15: 2550-2555.
11. Giuliano AE, Hunt KK, Ballman KV, et al.,: Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. J Am Med Assoc 2011; 305: 569-575.
12. Giuliano AE, McCall L, Beitsch P, et al.,: Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010; 252: 426-432.
13. Casabona F, Bogliolo S, Valenzano M, et al.,: Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol 2009; 16: 2459-2463.
14. Gobardhan PD, Wijsman JH, van Dalen T, et al.,: ARM: Axillary reverse mapping-The need for selection of patients. Eur J Surg Oncol 2012; 38: 657-661.
15. Ponzone R, Cont NT, Maggiorotto F:, Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer. J Clin Oncol 2009; 27: 5547-5551.
16. Rubio IT, Cebrecos I, Peg V, et al.,: Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer. J Surg Oncol 2012; 106: 89-93.
17. Tausch C, Baege A, Dietrich D, et al.,: Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients ? Eur J Surg Oncol 2013; 39: 880-886.
18. Ponzone R, Mininanni P, Cassina E, et al.,: Axillary reverse mapping in breast cancer: Can we spare what we find ? Ann Surg Oncol 2008; 15: 390-391.
19. Noguchi M, Yokoi M, Nakano Y:, Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. J Surg Oncol 2010; 101: 217-221.
20. Boneti C, Korourian S, Diaz Z, et al.,: Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg 2009; 198: 482-487.
21. Han JW, Seo YJ, Choi JE, et al.,: The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer. J Breast Cancer 2012; 15: 91-97.
22. Ikeda K, Ogawa Y, Komatsu H, et al.,: Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients. World J Surg Oncol 2012; 10: 233.
23. Ahmed RL, Prizment A, Lazovich D, et al.,: Lymphedema and quality of life in breast cancer survivors: The Iowa Women's Health Study. J Clin Oncol 2008; 26: 5689-5696.
24. Pavlista D, Eliska O:, Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla-A lesson from the past-Contribution to the concept of axillary reverse mapping. Eur J Surg Oncol 2012; 38: 390-394.
25. Pavlista D, Eliska O:, Relationship between the lymphatic drainage of the breast and the upper extremity: A postmortem study. Ann Surg Oncol 2012; 19: 3410-3415.